IVERIC bio (NASDAQ:ISEE) reported Q4 EPS of ($0.47), $0.10 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
IVERIC bio (NASDAQ:ISEE) reported Q4 EPS of ($0.47), $0.10 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .